Other Briefings
We cover the latest economy and trade, legal and tax updates, industry insights, and HR and payroll news that are most relevant to doing business in China. Here are our top China news summaries.
Shanghai Lingang New Area Releases Whitelists for Data Export, Facilitating Cross-Border Data Flows
Shanghai’s Lingang New Area has released general data lists that will facilitate data export for companies in the automotive, biopharma, and mutual fund sectors.
Tianjin Free Trade Zone Releases China’s First Negative List for Cross-Border Data Transfer
The Tianjin Free Trade Zone has released China’s first data Negative List outlining the types of data that must undergo a security review by China’s cybersecurity bureau to be transferred out of China.
China’s New Measures to Support Foreign Investment in Sci-tech Firms
China seeks to attract sci-tech foreign investment by relaxing rules, fostering partnerships, and enhancing the investment climate.
Shenzhen’s Qianhai Cooperation Zone Expands Preferential IIT and CIT Policies
The Shenzhen Municipal Tax Bureau, Shenzhen Municipal Finance Bureau, and State Tax Administration have issued two notices broadening tax incentives for individuals and companies in the Qianhai Cooperation Zone.
China Clarifies Medical Device Classification for Brain-Computer Interfaces: A Guide for Foreign Investors
NMPA’s new guideline sorts BCI devices into concrete risk classes and registration pathways, turning what used to be a regulatory guessing game into a roadmap foreign investors can actually plan around. Find out which devices get the fast-track Class II route, which face the full Class III gauntlet, and what it all means for your China market entry strategy.
Transfer Pricing in Hong Kong: BEPS 2.0, Documentation, and Trends
Hong Kong implemented the global minimum tax (Pillar Two) from January 1, 2025. This article examines the latest transfer pricing trends, documentation expectations, and what MNE groups should prepare.
China’s Medical Device Industry – Why Beijing is the Place to Invest
Beijing is fast becoming China’s leading hub for innovative medical devices, backed by dedicated industrial parks, policy incentives, and world-class research infrastructure. We look at where the opportunities lie for foreign companies and how to position for market entry.
China’s 2026 Legislative Agenda: Which Laws Matter Most for Foreign Businesses?
Under the new agenda, China will introduce major reforms to procurement, trademarks, taxation, bankruptcy, and financial regulations. These changes, which aim to unify rules, tighten compliance, and reshape market access, could require foreign companies to reassess strategies and regulatory exposure.
China Strengthens Trademark Enforcement: What the 2026 Amendment Means for Businesses
The new amendment strengthens mechanisms for brand protection for rights holders while introducing new compliance obligations that businesses must address ahead of the January 2027 implementation date.
China Manufacturing Tracker 2026
Our tracker provides continuous updates on key economic and growth indicators in China’s manufacturing industry. The data for May 2026 has now been updated.
China’s Maternity and Baby Market (Part II): Key Segments and Opportunities for Foreign Brands
China’s maternity and baby market offers clear opportunities for foreign brands. But the market is competitive, regulated, and highly segmented. Part II maps the key product and service segments, the real challenges foreign entrants face, and where the strongest opportunities lie.
Hong Kong’s Evolving Double Tax Agreement (DTA) Network 2026
Hong Kong’s double tax agreement network has reached a new milestone, with fresh treaties and active negotiations shaping the 2026 outlook. Understanding how Hong Kong’s DTAs work is essential for investors and multinationals planning cross-border operations.
